Dn B Asset Management As Amicus Therapeutics, Inc. Transaction History

Dn B Asset Management As

  • $25.3 Billion
  • Q3 2025

A detailed history of Dn B Asset Management As transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 46,161 shares of FOLD stock, worth $437,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,161
Previous 35,519 29.96%
Holding current value
$437,606
Previous $289,000 25.61%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
BUY
$5.84 - $8.57 $62,149 - $91,201
10,642 Added 29.96%
46,161 $363,000
Q1 2025

May 15, 2025
BUY
$8.16 - $9.85 $25,108 - $30,308
3,077 Added 9.48%
35,519 $289,000
Q4 2024

Feb 12, 2025
SELL
$9.36 - $12.01 $2,162 - $2,774
-231 Reduced 0.71%
32,442 $305,000
Q3 2024

Nov 12, 2024
BUY
$9.55 - $12.09 $4,679 - $5,924
490 Added 1.52%
32,673 $348,000
Q2 2024

Jul 05, 2024
BUY
$9.04 - $11.75 $46,691 - $60,688
5,165 Added 19.12%
32,183 $319,000
Q1 2024

Apr 12, 2024
BUY
$11.43 - $14.24 $24,940 - $31,071
2,182 Added 8.79%
27,018 $318,000
Q4 2023

Jan 04, 2024
BUY
$9.97 - $14.52 $5,483 - $7,986
550 Added 2.26%
24,836 $352,000
Q3 2023

Oct 13, 2023
SELL
$11.78 - $13.86 $69,537 - $81,815
-5,903 Reduced 19.55%
24,286 $295,000
Q2 2023

Jul 06, 2023
BUY
$10.72 - $13.3 $94,528 - $117,279
8,818 Added 41.26%
30,189 $379,000
Q1 2023

Apr 20, 2023
BUY
$10.91 - $13.54 $35,097 - $43,558
3,217 Added 17.72%
21,371 $237,000
Q4 2022

Jan 12, 2023
SELL
$9.89 - $12.7 $28,918 - $37,134
-2,924 Reduced 13.87%
18,154 $222 Million
Q3 2022

Oct 11, 2022
SELL
$9.82 - $12.75 $45,338 - $58,866
-4,617 Reduced 17.97%
21,078 $220,000
Q2 2022

Jul 08, 2022
BUY
$6.23 - $11.12 $160,079 - $285,728
25,695 New
25,695 $276 Million
Q1 2022

Apr 08, 2022
SELL
$7.89 - $12.48 $180,183 - $285,005
-22,837 Closed
0 $0
Q4 2021

Jan 12, 2022
SELL
$9.82 - $12.44 $1.49 Million - $1.88 Million
-151,441 Reduced 86.9%
22,837 $263,000
Q3 2021

Oct 15, 2021
BUY
$8.74 - $11.84 $1.31 Million - $1.77 Million
149,898 Added 614.84%
174,278 $1.66 Million
Q2 2021

Jul 06, 2021
BUY
$8.71 - $10.72 $212,349 - $261,353
24,380 New
24,380 $235 Million
Q1 2021

Apr 15, 2021
SELL
$9.2 - $23.86 $144,697 - $375,270
-15,728 Closed
0 $0
Q4 2020

Jan 19, 2021
SELL
$13.47 - $24.89 $172,712 - $319,139
-12,822 Reduced 44.91%
15,728 $363,000
Q3 2020

Oct 14, 2020
SELL
$12.89 - $15.89 $363,730 - $448,384
-28,218 Reduced 49.71%
28,550 $403,000
Q2 2020

Jul 08, 2020
BUY
$8.86 - $15.69 $502,964 - $890,689
56,768 New
56,768 $856 Million

Others Institutions Holding FOLD

# of Institutions
310
Shares Held
315M
Call Options Held
935K
Put Options Held
991K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.66B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email